Got $2,000 in Cash? Put It Into This Company Testing for Coronavirus in Pro Sports
Amidst record levels of market volatility caused by the COVID-19 pandemic, one set of stocks that has performed extraordinarily well is made up of companies engaged in coronavirus testing. Take the example of Opko Health (NASDAQ: OPK), which runs BioReference, one of the nation's leading clinical laboratories.
Since the beginning of the year, shares of Opko Health have gone up by 280%. A modest investment of $2,000 in January would have grown to $7,606 in the span of seven months -- and the party is far from over. Opko Health is at a pivotal stage in its expansion efforts, which I believe will further enrich investors. Let's take a look as to why.
Image source: Getty Images.
Source Fool.com
